导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.65% | 301/1050 |
| 近一周 | -0.50% | 65/1104 |
| 近一月 | 2.89% | 17/1102 |
| 近一季 | 6.05% | 113/1092 |
| 近半年 | 5.28% | 312/1070 |
| 近一年 | 13.74% | 310/1018 |
| 近两年 | 37.78% | 610/926 |
| 近三年 | 14.92% | 551/834 |
| 成立以来 | 63.24% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.38% 236/1070 |
-7.81% 861/1101 |
- - |
- - |
| 2025 | 3.92% 898/1065 |
-0.58% 833/1014 |
1.59% 543/1038 |
-2.54% 1022/1050 |
5.58% 116/1065 |
| 2024 | 4.09% 458/1011 |
-2.24% 432/960 |
-1.41% 401/983 |
9.87% 629/991 |
-1.71% 427/1011 |
| 2023 | 3.33% 56/952 |
9.45% 130/880 |
1.21% 124/895 |
-3.60% 233/915 |
-3.24% 346/952 |
| 2022 | -10.77% 94/867 |
-8.18% 69/773 |
4.24% 566/806 |
-6.94% 107/845 |
0.19% 437/867 |
| 2021 | 6.05% 288/740 |
3.19% 75/580 |
2.31% 506/659 |
-1.59% 246/704 |
2.07% 352/740 |
| 2020 | 8.76% 399/554 |
-9.20% 373/419 |
5.79% 411/466 |
7.29% 315/517 |
5.53% 426/554 |
| 2019 | 19.67% 332/410 |
13.59% 1021/1149 |
-1.18% 457/1231 |
-0.01% 331/390 |
6.63% 291/410 |
| 2018 | -15.60% 29/349 |
- - |
- - |
- - |
-6.89% 100/1080 |
| 2017 | 19.63% 83/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇丰晋信大盘波动股票A VS. 东吴新产业精选股票A(580008) |